Mapping of DOG1 expression in colorectal carcinomas
Pathology · 2026-06 · 58 (4) · 383-392
DOI: 10.1016/j.pathol.2025.12.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology, 2026-06. Verfasst von Julie Baron und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Anatomie et Cytologie Pathologiques, CHU Nantes, France. Hauptthemen laut MEDLINE: Anoctamin-1, Colorectal Neoplasms, Neoplasm Proteins, Biomarkers, Tumor. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Direction de l'hospitalisation et de l'organisation des soins, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Discovery on Gastrointestinal stromal tumour (DOG1) could deliver mitogen/survival signalling in colorectal carcinoma (CRC) cell lines. DOG1 is a major calcium-activated chloride channel expressed in mesenchymal and epithelial cells where it governs secretion of fluid and mucus. This study details DOG1 expression in various histopathological subtypes of CRC and assesses the relationship between DOG1 expression and an immunophenotype based on the secreted gel-forming mucins, as well as molecular groups of CRCs. A selection of 93 CRCs was analysed for clinicopathological data, RAS and BRAF mutations, microsatellite instability status, and mismatch-repair proteins (MLH1, MSH2, MSH6, PMS2). Their DOG1, MUC2, MUC5AC, MUC6, CDX2, keratin-20, and keratin-7 immunoprofiles were then compared with histopathology and molecular features of CRC. The prognostic relevance of DOG1 was assessed using univariate and multivariate survival analyses. DOG1 was detected in neoplastic cells and cancer-associated fibroblasts (CAFs) of 45 and 41 CRCs, respectively. In a clustering study, high expression of DOG1 in neoplastic cells was found in (i) various histological subtypes of adenocarcinomas with a gastric-like phenotype, BRAF mutation, and microsatellite instability high (MSI-H) and (ii) adenocarcinomas with a mucinous component, KRAS mutation, and microsatellite stability status (MSS). CAF DOG1 expression was identified in MSS conventional adenocarcinomas. DOG1 expression in tumour cells was associated with no benefit from adjuvant chemotherapy. DOG1-positive CAFs were associated with better overall survival. This study suggests that DOG1 expression is detected in a high proportion of CRC because it is expressed in neoplastic cells of various histological subtypes of CRC that secrete gel-forming mucins, independently of mucinous features or in CAFs of conventional adenocarcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Anatomie et Cytologie Pathologiques, CHU Nantes, France.
- Laboratoire de Biochimie, CHU Nantes, France.
- Chirurgie Cancérologique Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif (IMAD), CHU Nantes, France.
- Service d'Anatomie et Cytologie Pathologiques, CHU Nantes, France. Electronic address: jfmosnier@live.fr.
Förderung
- Direction de l'hospitalisation et de l'organisation des soins
- Institut National de la Santé et de la Recherche Médicale
Zitieren
APA
Baron, J., Lagrue, E., Normand, A., Denis, M. G., Duchalais, E., & Mosnier, J. F. (2026). Mapping of DOG1 expression in colorectal carcinomas. Pathology, 58(4), 383-392. https://doi.org/10.1016/j.pathol.2025.12.003
Vancouver
Baron J, Lagrue E, Normand A, Denis MG, Duchalais E, Mosnier JF. Mapping of DOG1 expression in colorectal carcinomas. Pathology. 2026;58(4):383-392. doi:10.1016/j.pathol.2025.12.003
BibTeX
@article{Baron2026,
author = {Baron, Julie and Lagrue, Eric and Normand, Adeline and Denis, Marc G and Duchalais, Emilie and Mosnier, Jean-François},
title = {Mapping of DOG1 expression in colorectal carcinomas},
journal = {Pathology},
year = {2026},
volume = {58},
number = {4},
pages = {383--392},
doi = {10.1016/j.pathol.2025.12.003}
}
EUVIMED